GE HEALTHCARE TECHNOLOGIES INC. Net Income (Loss) Attributable to Redeemable Noncontrolling Interest
GE HEALTHCARE TECHNOLOGIES INC. (GEHC) reported Net Income (Loss) Attributable to Redeemable Noncontrolling Interest of $21.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest · last filed 2026-04-29
- GE HEALTHCARE TECHNOLOGIES INC. net income (loss) attributable to redeemable noncontrolling interest for the quarter ending 2026-03-31 was $21.00M, a 12.50% decline year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. net income (loss) attributable to redeemable noncontrolling interest for the quarter ending 2025-12-31 was $12.00M, a 20.00% decline year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. net income (loss) attributable to redeemable noncontrolling interest for the quarter ending 2025-09-30 was $17.00M, a 10.53% decline year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. net income (loss) attributable to redeemable noncontrolling interest for the quarter ending 2025-06-30 was $13.00M, a 160.00% increase year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. net income (loss) attributable to redeemable noncontrolling interest for fiscal 2025 was $66.00M, a 32.00% increase from fiscal 2024.
- GE HEALTHCARE TECHNOLOGIES INC. net income (loss) attributable to redeemable noncontrolling interest for fiscal 2024 was $50.00M, a 21.95% increase from fiscal 2023.
- GE HEALTHCARE TECHNOLOGIES INC. net income (loss) attributable to redeemable noncontrolling interest for fiscal 2023 was $41.00M, a 12.77% decline from fiscal 2022.
- GE HEALTHCARE TECHNOLOGIES INC. net income (loss) attributable to redeemable noncontrolling interest for fiscal 2022 was $47.00M, a 20.51% increase from fiscal 2021.
| Period end | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-03-31 | $21.00M 10-Q · filed 2026-04-29 | $33.00M derived: sum of 2 quarters · filed 2026-04-29 | $50.00M derived: sum of 3 quarters · filed 2026-04-29 | $63.00M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $29.00M derived: sum of 2 quarters · filed 2026-02-04 | $42.00M derived: sum of 3 quarters · filed 2026-02-04 | $66.00M 10-K · filed 2026-02-04 |
| 2025-09-30 | $17.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $30.00M derived: sum of 2 quarters · filed 2025-10-29 | $54.00M 10-Q · filed 2025-10-29 | $69.00M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | $13.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $37.00M 10-Q · filed 2025-07-30 | $52.00M derived: sum of 3 quarters · filed 2026-04-29 | $71.00M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | $24.00M 10-Q · filed 2026-04-29 | $39.00M derived: sum of 2 quarters · filed 2026-04-29 | $58.00M derived: sum of 3 quarters · filed 2026-04-29 | $63.00M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $34.00M derived: sum of 2 quarters · filed 2026-02-04 | $39.00M derived: sum of 3 quarters · filed 2026-02-04 | $50.00M 10-K · filed 2026-02-04 |
| 2024-09-30 | $19.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $24.00M derived: sum of 2 quarters · filed 2025-10-29 | $35.00M 10-Q · filed 2025-10-29 | $48.00M derived: sum of 4 quarters · filed 2026-02-04 |
| 2024-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $16.00M 10-Q · filed 2025-07-30 | $29.00M derived: sum of 3 quarters · filed 2026-02-04 | $36.00M derived: sum of 4 quarters · filed 2026-02-04 |
| 2024-03-31 | $11.00M 10-Q · filed 2025-04-30 | $24.00M derived: sum of 2 quarters · filed 2026-02-04 | $31.00M derived: sum of 3 quarters · filed 2026-02-04 | $42.00M derived: sum of 4 quarters · filed 2026-02-04 |
| 2023-12-31 | $13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $20.00M derived: sum of 2 quarters · filed 2026-02-04 | $31.00M derived: sum of 3 quarters · filed 2026-02-04 | $41.00M 10-K · filed 2026-02-04 |
| 2023-09-30 | $7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $18.00M derived: sum of 2 quarters · filed 2024-10-30 | $28.00M 10-Q · filed 2024-10-30 | $51.00M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $11.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $21.00M 10-Q · filed 2024-07-31 | $44.00M derived: sum of 3 quarters · filed 2025-02-13 | $49.00M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $10.00M 10-Q · filed 2024-04-30 | $33.00M derived: sum of 2 quarters · filed 2025-02-13 | $38.00M derived: sum of 3 quarters · filed 2025-02-13 | $48.00M derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $23.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $28.00M derived: sum of 2 quarters · filed 2025-02-13 | $38.00M derived: sum of 3 quarters · filed 2025-02-13 | $47.00M 10-K · filed 2025-02-13 |
| 2022-09-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $15.00M derived: sum of 2 quarters · filed 2023-10-31 | $24.00M 10-Q · filed 2023-10-31 | |
| 2022-06-30 | $10.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | $19.00M 10-Q · filed 2023-07-25 | ||
| 2022-03-31 | $9.00M 10-Q · filed 2023-04-25 | |||
| 2021-12-31 | $39.00M 10-K · filed 2024-02-06 |